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The Changing Epidemiology
of Infective Endocarditis
The Paradox of Prophylaxis in the
Current and Future Eras*
Andrew Wang, MD
Durham, North Carolina
“The future ain’t what it used to be.”
—Yogi Berra (1)
Infective endocarditis (IE), or infection of an endocardial
surface of the heart, remains an uncommon disease associated
with significant morbidity, including complications of heart fail-
ure, stroke, systemic embolization, and sepsis. Despite continued
progress in the diagnosis and treatment of this condition, IE
continues to have an in-hospital mortality of approximately
20%, essentially unchanged over the past 2 decades (2).
See page 1968
Given the persistently high rate of morbidity and mor-
tality of this condition, increased efforts to reduce the
incidence of IE seem logical and needed. However, within
the past 5 years, the most recent guidelines from the
American College of Cardiology, American Heart Associ-
ation, and European Society of Cardiology have recom-
mended a more restrictive use of antibiotic prophylaxis for
the prevention of IE (3,4). Although studies have shown a
reduced rate of bacteremia with the use of antibiotic therapy
prior to dental extraction, bacteremia may result from
routine activities of daily living more commonly than
exposure to medical interventions (3). Furthermore, conclu-
sive data to demonstrate a causal reduction in the rate of
procedure-related IE with antibiotic prophylaxis is lacking,
and the benefit of prophylaxis (if any) does not clearly
exceed the adverse effects of antibiotic use (3).
Therefore, these scientific organizations have limited
recommendations for prophylaxis to those patients in whom
IE, if it occurred, would be estimated to have an even worse
prognosis than the general population. Specifically, the
American College of Cardiology/American Heart Associa-
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recommends antibiotic prophylaxis for predisposing heart
conditions including prosthetic cardiac valve replacement or
prosthetic material for valve repair, previous history of IE,
congenital heart disease (specifically, unrepaired cyanotic
lesions, including palliative shunts and conduits, repaired
lesions with prosthetic material in the first 6 months following
the procedure, or repaired conditions with residual defect at the
site or adjacent to site of prosthetic material), and transplant
recipients who develop valvulopathy (3).
In order to reduce the incidence of IE and improve its
outcome, epidemiological studies may provide insights into
contemporary, modifiable risks for IE and its morbidity and
mortality. The pathogenesis and prognosis of IE can be simply
described by the interaction between host and pathogen. These
broad factors are not independent, but rather, strongly linked
such that changes in host characteristics may influence their
susceptibility to acquiring and surviving specific pathogens, and
vice versa. As a result of this complex interaction, observations
regarding changes in the epidemiology challenge physicians to
define means to influence its outcome.
In this issue of the Journal, a well-established and
recognized group of IE investigators, L’Association pour
l’Etude et la Prévention de l’Endocardite Infectieuse
(AEPEI), have compared IE clinical characteristics across 3
different eras over a range of 18 years in 3 French regions
(5). Cases of IE were identified by surveys sent to physicians
in the regions’ hospitals, and the cases of definite IE were
carefully validated by available case definitions (von Reyn
criteria [6] modified to include echocardiographic findings
in 1991 and 1999 and the modified Duke criteria [7] in
2008). With a similar number of cases identified in the 3
time periods, significant changes in host characteristics were
identified, including increased age, prevalence of diabetes
mellitus, presence of cardiac devices, and a decreased prev-
alence of predisposing native valve condition.
Although the incidence of IE in this survey, determined
by number of validated IE cases per total population in these
regions, remained unchanged from 1991 to 2008, the study
found an increased rate of Staphylococcus aureus as the cause
of infection in patients without predisposing native valve
conditions (3). By contrast, the incidence of streptococcal
IE was stable during the study period, both in the overall
cohort as well as in patients with predisposing native valve
disease. This rate of streptococcal infection was unchanged
despite the progressive reduction in recommendation for pro-
phylaxis before dental and other medical procedures, although
the adoption of these guidelines was only 60% (5). Finally,
espite a higher rate of surgical intervention (50% in 2008),
n-hospital mortality remained approximately 20% (5).
These findings confirm the results of several previous
tudies, which described changes in the epidemiology of IE
ver the past 20 years (2,8,9). Reports from the mid-1990s
escribed the typical case of IE as affecting a patient in the
fth decade of life with predisposing native valve condition
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in the late 1990s, S. aureus became increasingly apparent as
a common cause of IE, not only associated with injection
drug use, but also in cohorts with increasing rates of
hemodialysis and immunosuppression, and a lower rate of
predisposing valve condition (8). Thus, in 2000, the Duke
criteria for IE were modified to include S. aureus as a
“typical” causative organism (7), now the most common
cause of both native and prosthetic valve IE.
Recent studies have highlighted the strong association
between changes in host factors (advanced age, higher
prevalence of comorbid conditions) and S. aureus infection
(11). This link between host factors and S. aureus in IE
eems to be determined paradoxically by increased medical
nterventions and exposure to health care (11,12), rather
han a lack of access to medical care. “Healthcare-
ssociated” (HCA) IE is defined as infection acquired
uring hospitalization (nosocomial) or in a patient with
xtensive out-of-hospital contact with healthcare interven-
ions or systems (including outpatient intravenous therapy,
ound care, or specialized nursing care at home within the 30
ays; hemodialysis or intravenous chemotherapy within 30
ays; hospitalization for 2 or more days within the 90 days; or
esidence in a nursing home or long-term care facility) (13).
Observational studies from diverse geographic regions
ave found that HCA infection can be identified in approx-
mately 30% of IE cases (2). This variable also integrates
nvironmental factors, particularly the influence of health-
are systems and resources, in the incidence and prognosis
f IE. Significant regional differences in IE characteristics,
ncluding pre-disposing conditions for healthcare-related
nfection that are most prevalent in the United States, have
een found (11,12). These comorbid conditions further
ffect outcome of IE by influencing its treatment: HCA
nfection and S. aureus IE are associated with a lower
ikelihood of surgical intervention despite high rates of
ntibiotic resistance and complications (12,14–16). Not
urprisingly, HCA IE has a worse prognosis than
ommunity-acquired infection (12).
How can cardiologists and cardiac surgeons help reduce
he incidence of IE and its high mortality rate in the setting
f such epidemiological changes and challenges? Observed
rends in adverse host factors, in conjunction with increased
se of advanced medical therapies and resultant exposure to
. aureus, have rendered ineffective the preventive strategies
f yesteryear. Education regarding risks of HCA infection
nd careful management of susceptible patients, particularly
hose with cardiac devices and significant comorbid condi-
ions, may be a more compelling preventive strategy moving
orward. In the more customary realms of diagnosis and
reatment, care of the patient with IE should be multidis-
iplinary, experienced, and focused on appropriate antibiotic
herapy and use of surgery to improve survival (17). Finally,
urther research on modifiable, procedural-related factors forCA IE, rather than simply host characteristics, and new
trategies to deliver safer health care to the host at risk should
ngage all care providers, particularly now that prevention of
E is not as simple as it seemed in the good old days.
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